|
Home : Unsafe Drugs : Avandia : News Articles : The week ahead – April 26, 2011: results, meetings and trading updates - Telegraph The week ahead – April 26, 2011: results, meetings and trading updates - Telegraph
The charge – announced in January – partly related to litigation around Glaxo's diabetes drug, Avandia. When Glaxo updates the market this week, investors might well be interested to hear more about Glaxo's reasons for selling off Alli, its weight loss drug, as part of an overhaul of its non-prescription medicine business. Earlier this month, the drug maker said that ...
Avandia Case Evaluation Form
This form is secure and encrypted. More information about secure forms and your privacy here.
|




